| # | Drug | Count |
|---|---|---|
| 0 | LAMOTRIGINE | 5 |
| 1 | UPADACITINIB | 5 |
| 2 | ERGOCALCIFEROL | 4 |
| 3 | FOLIC ACID | 4 |
| 4 | INFLIXIMAB | 4 |
| 5 | NATALIZUMAB | 4 |
| 6 | RISANKIZUMAB-RZAA | 4 |
| 7 | ADALIMUMAB | 3 |
| 8 | CERTOLIZUMAB PEGOL | 3 |
| 9 | CETIIRIZINE | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMINOCAPROIC ACID | 1 | 0.0012 |
| 1 | 12%AZELAIC ACID | 1 | 0.0012 |
| 2 | AZELAIC ACID | 1 | 0.0010 |
| 3 | AVALGLUCOSIDASE ALFA-NGPT | 1 | 0.0010 |
| 4 | COAGULATION FACTOR IX RECOMBINANT HUMAN | 1 | 0.0009 |
| 5 | CLOMIPHENE CITRATE | 1 | 0.0007 |
| 6 | ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE | 1 | 0.0006 |
| 7 | ALGLUCOSIDASE ALFA | 1 | 0.0004 |
| 8 | ELAGOLIX | 1 | 0.0003 |
| 9 | SOLRIAMFETOL | 1 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 7 |
| 1 | Mood Stabilizer [EPC] | 7 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 7 |
| 3 | Anti-epileptic Agent [EPC] | 6 |
| 4 | Integrin Receptor Antagonist [EPC] | 6 |
| 5 | GLP-1 Receptor Agonist [EPC] | 5 |
| 6 | Interleukin-23 Antagonist [EPC] | 5 |
| 7 | Janus Kinase Inhibitor [EPC] | 5 |
| 8 | Provitamin D2 Compound [EPC] | 4 |
| 9 | Vitamin B12 [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 2 | 0.0006 |
| 1 | Dopamine and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Vitamin K [EPC] | 2 | 0.0002 |
| 3 | Non-Standardized Insect Allergenic Extract [EPC] | 1 | 0.0002 |
| 4 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Standardized Insect Venom Allergenic Extract [EPC] | 1 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 8 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 9 | Bile Acid [EPC] | 2 | 0.0001 |